Injection of colored silicone into the vascular tree can enhance the educational value of cadaveric head dissections. This report describes the technique of vascular injection that is used in the Goodyear Microsurgical Laboratory, the University of Cincinnati, and the Mayfield Clinic.

Object The purpose of this study was to elucidate the anatomy of the trigeminal nerve (cranial nerve [CN] V), Meckel cave (MC), and lateral wall of the cavernous sinus (CS). Methods Ten fresh cadaver heads (20 sides) and 2 middle fossa embalmed specimens were removed, decalcified, sectioned, stained, and studied microscopically. Results In the MC, the posterior fossa meningeal dura extended into the middle fossa surrounding CN V. The average medial length of the MC was 16.7 mm and the lateral length was 13.5 mm. The dural roof of MC was thicker than its floor and was covered by a paw-shaped fibrous tissue extending from the tentorium to the ganglion (in 100% of specimens). Between the dural sleeve of the MC and venous space of the CS, a separate fibrous wall could be identified in 45% (9 of 20) extending between the tentorium and the floor of the CS. The mean length of CN V in the MC proximal to the posterior margin of the Gasserian ganglion was 11.8 mm. The mean length of CN V1 was 19.4 mm; V2, 12.3 mm; and V3, 7.4 mm distal to the anterior margin of the ganglion. The periosteal dura followed the bone of the middle fossa and was continuous with the extracranial periosteum. The lateral dural wall of the CS consisted of a medial (membranous) and a lateral wall. The latter was separated into a thin outer layer and a thicker fibrous inner layer that became thinner as it extended posterolaterally. Conclusions The MC is an extension of the posterior fossa dura with intricate relationships with the surrounding dural layers.

Object The optimal surgical management of Chiari malformation (CM) is evolving. Evidence continues to accrue that supports decompression without duraplasty as an effective treatment to achieve symptomatic relief and anatomical decompression. The risks and benefits of this less invasive operation need to be weighed against decompression with duraplasty. Methods The authors performed a retrospective review of all CM decompressions from 2003 to 2007. All operations were performed by a single surgeon at a single institution. Data were analyzed for outcome, postoperative morbidity, and recurrence. Results Of 121 unique patients, 56 underwent posterior fossa decompressions without duraplasty (PFD) and 64 patients underwent posterior fossa decompressions with duraplasty (PFDD). Of the 56 PFD patients, 7 (12.5%) needed a subsequent PFDD for symptomatic recurrence. Of the 64 patients who underwent a PFDD, 2 (3.1%) needed a repeated PFDD for symptomatic recurrence. Patients treated with PFDD had an average operative time of 201 minutes in contrast to 127 minutes for those who underwent PFD (p = 0.0001). Patients treated with PFDD had average hospital stays of 4.0 days, whereas that for patients treated with PFD was 2.7 days (p = 0.0001). While in the hospital, patients treated with PFDD used low-grade narcotics, intravenous narcotics, muscle relaxants, and antiemetic medications at statistically significant differing rates. Conclusions While PFD was associated with a higher rate of recurrent symptoms requiring repeated decompression, this may be justified by the significantly lower morbidity rate. Clearer delineation of the trade-off between morbidity and recurrence may be used to help patients and their families make decisions regarding care.

This multicenter experience represents the largest reported series of balloon-augmented Onyx embolization of cerebral AVMs. The technique appears safe and effective in the treatment of AVMs, allowing more efficient and controlled injection of Onyx with a decreased risk of reflux and decreased fluoroscopy times.